View by Specialty

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
July 18, 2024
2 min read
Save

Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection

Body fat, metabolic changes before pancreatic cancer diagnosis may aid in early detection

In the 36 months prior to diagnosis of pancreatic ductal adenocarcinoma, researchers observed “predominant changes” in patients’ body composition and biochemical markers, which may serve as potential biomarkers for early cancer detection.

SPONSORED CONTENT
July 17, 2024
2 min read
Save

Timing of adjuvant chemotherapy affects outcomes after colorectal cancer surgery

Timing of adjuvant chemotherapy affects outcomes after colorectal cancer surgery

Timing of adjuvant chemotherapy initiation may affect outcomes among patients who undergo surgery for colorectal cancer, according to data published in JAMA Surgery.

Trending

IDC1024Hoberman_graphic
November 04, 2024
4 min read
Save

Q&A: App ‘much better’ than physicians at diagnosing ear infections

SPONSORED CONTENT
July 12, 2024
4 min read
Save

Q&A: AI chatbot helps make colonoscopy prep ‘a little less painful’ for patients

Q&A: AI chatbot helps make colonoscopy prep ‘a little less painful’ for patients

AI has already made its mark in gastroenterology as a tool for detecting gastrointestinal lesions, adenomas and inflammatory bowel disease. However, its next phase of evolution might seem the most unlikely: Aiding colonoscopy preparation.

SPONSORED CONTENT
July 11, 2024
2 min read
Save

Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors

Nearly half of cancer deaths among U.S. adults attributable to modifiable risk factors

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

SPONSORED CONTENT
July 10, 2024
2 min read
Save

CRC screening trials exhibit ‘good adherence’ to guidelines, but improvements needed

CRC screening trials exhibit ‘good adherence’ to guidelines, but improvements needed

Although adherence to standardized reporting guidelines ranged from 82.4% to 92.2% in published trials of colorectal cancer screening, researchers found that reporting of trial registration and informed consent materials could be improved.

SPONSORED CONTENT
July 10, 2024
2 min read
Save

Risk score has ‘superior ability’ to predict LT waitlist dropout among patients with HCC

Risk score has ‘superior ability’ to predict LT waitlist dropout among patients with HCC

A continuous risk score accurately predicted waitlist dropout and post-liver transplantation outcomes in patients with hepatocellular carcinoma, even over the course of several UNOS policy changes, researchers reported.

SPONSORED CONTENT
July 05, 2024
2 min read
Save

CRC screening based on fecal hemoglobin levels could reduce other testing by up to 49%

CRC screening based on fecal hemoglobin levels could reduce other testing by up to 49%

Using fecal hemoglobin concentrations to guide colorectal cancer screening intervals reduced the number of fecal immunochemical tests and colonoscopies by 49% and 28%, respectively, compared with biennial screening, data showed.

SPONSORED CONTENT
June 28, 2024
2 min read
Save

Individuals with high genetic risk for gastric cancer may benefit from H. pylori treatment

Individuals with high genetic risk for gastric cancer may benefit from <i>H. pylori</i> treatment

Treatment for Helicobacter pylori infection was associated with reduced risk for gastric cancer among patients with a high genetic risk, suggesting that chemoprevention should be personalized to genetic risk, according to data.

SPONSORED CONTENT
June 21, 2024
1 min read
Save

Adagrasib plus cetuximab receives accelerated approval to treat advanced colorectal cancer

Adagrasib plus cetuximab receives accelerated approval to treat advanced colorectal cancer

The FDA granted accelerated approval adagrasib with cetuximab for the treatment of KRASG12C -mutated locally advanced or metastatic colorectal cancer, according to a press release from the agency.

SPONSORED CONTENT
June 21, 2024
2 min read
Save

National accreditation program linked to better outcomes after major rectal cancer surgery

National accreditation program linked to better outcomes after major rectal cancer surgery

National Accreditation Program for Rectal Cancer accreditation appeared associated with better outcomes for older adults who underwent major rectal cancer surgery, according to findings in Journal of the American College of Surgeons.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails